<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-viruses-11-00742">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Perelygina</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hautala</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sepp√§nen</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Adebayo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sullivan</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Icenogle</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>147</volume>
  <fpage>58</fpage>
  <lpage>66</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.09.019</pub-id>
  <?supplied-pmid 28974385?>
  <pub-id pub-id-type="pmid">28974385</pub-id>
 </element-citation>
</ref>
